{"data":{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:29681787", "kind": "science-record", "revision": 8, "content_hash": "sha256:0ee26f58b9f8c7ae5b6e2e7f4a63b781e947ce4a85076ff7f1f8a6e8e2b94b5b", "created_at": "2026-11-01T15:40:33Z", "updated_at": "2026-11-01T22:43:21Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature.", "doi": "10.1186/s12014-018-9192-2", "pmid": "29681787", "authors": ["Anaïs Chauvin", "Chang-Shu Wang", "Sameh Geha", "Perrine Garde-Granger", "Alex-Ane Mathieu", "Vincent Lacasse", "François-Michel Boisvert"], "journal": "Clinical proteomics", "year": 2018, "abstract": "BACKGROUND: Colorectal cancer is the third most common and the fourth most lethal cancer in the world. In the majority of cases, patients are diagnosed at an advanced stage or even metastatic, thus explaining the high mortality. The standard treatment for patients with locally advanced non-metastatic rectal cancer is neoadjuvant radio-chemotherapy (NRCT) with 5-fluorouracil (5-FU) followed by surgery, but the resistance rate to this treatment remains high with approximately 30% of non-responders. The lack of evidence available in clinical practice to predict NRCT resistance to 5-FU and to guide clinical practice therefore encourages the search for biomarkers of this resistance.\nMETHODS: From twenty-three formalin-fixed paraffin-embedded (FFPE) biopsies performed before NRCT with 5-FU of locally advanced non-metastatic rectal cancer patients, we extracted and analysed the tumor proteome of these patients. From clinical data, we were able to classify the twenty-three patients in our cohort into three treatment response groups: non-responders (NR), partial responders (PR) and total responders (TR), and to compare the proteomes of these different groups.\nRESULTS: We have highlighted 384 differentially abundant proteins between NR and PR, 248 between NR and TR and 417 between PR and TR. Among these proteins, we have identified many differentially abundant proteins identified as having a role in cancer (IFIT1, FASTKD2, PIP4K2B, ARID1B, SLC25A33: overexpressed in TR; CALD1, CPA3, B3GALT5, CD177, RIPK1: overexpressed in NR). We have also identified that DPYD, the main degradation enzyme of 5-FU, was overexpressed in NR, as well as several ribosomal and mitochondrial proteins also overexpressed in NR. Data are available via ProteomeXchange with identifier PXD008440.\nCONCLUSIONS: From these retrospective study, we implemented a protein extraction protocol from FFPE biopsy to highlight protein differences between different response groups to RCTN with 5-FU in patients with locally advanced non-metastatic rectal cancer. These results will pave the way for a larger cohort for better sensitivity and specificity of the signature to guide decisions in the choice of treatment.", "claims": [{"id": "claim-method", "statement": "Finally, the analysis of mass spectrometry data were next carried out with the Perseus software package [19] and subjected to a normalization (z-score) and an ANOVA statistical test (comparison of the three groups) or Student’s T test (comparison of two groups), both corrected with a p value of 0.05.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:29681787", "locator": "sections[13] \"Quantification and bioinformatics analysis\" paragraph 2", "quote": "Finally, the analysis of mass spectrometry data were next carried out with the Perseus software package [19] and subjected to a normalization (z-score) and an ANOVA statistical test (comparison of the three groups) or Student’s T test (comparison of two groups), both corrected with a p value of 0.05."}], "state": "complete"}, {"id": "claim-data-access", "statement": "All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:29681787", "locator": "sections[26] \"ack\" paragraph 1", "quote": "All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440."}], "state": "complete"}, {"id": "claim-target-result", "statement": "The paper highlighted 384 differentially abundant proteins between non-responders and partial responders, using ANOVA and Student’s T test for statistical comparisons, and deposited the source proteomics data in ProteomeXchange under identifier PXD008440.", "kind": "quantitative", "target": {"value": 0.05, "unit": "p-value", "tolerance": null, "source": "Statistical tests used for these analyses are ANOVA test (1) and Student’s T test (2) both corrected with a p value of 0.05."}, "evidence": [{"asset": "source:pmid:29681787", "locator": "sections[0] \"Abstract\" paragraph 3", "quote": "We have highlighted 384 differentially abundant proteins between NR and PR, 248 between NR and TR and 417 between PR and TR."}, {"asset": "source:pmid:29681787", "locator": "sections[19] \"Identification of differentially abundant proteins between groups\" paragraph 3", "quote": "Statistical tests used for these analyses are ANOVA test (1) and Student’s T test (2) both corrected with a p value of 0.05."}, {"asset": "source:pmid:29681787", "locator": "sections[0] \"Abstract\" paragraph 3", "quote": "Data are available via ProteomeXchange with identifier PXD008440."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "The paper highlighted 384 differentially abundant proteins between non-responders and partial responders, using ANOVA and Student’s T test for statistical comparisons, and deposited the source proteomics data in ProteomeXchange under identifier PXD008440.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:29681787"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD008440"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {"p_value": ", both corrected with a p value of 0"}, "inputs": ["data:geo:PXD008440"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:29681787", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1186/s12014-018-9192-2", "sha256": "sha256:75275a7d036c6c519b66605147a8a5c48fd56a9a13457c9b81305d26f0a5903a", "bytes": 51777, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1186/s12014-018-9192-2", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC5898006", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD008440", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD008440", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD008440", "version": null, "note": "All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "The response to neoadjuvant chemoradiotherapy to 5-fluorouracil in locally advanced colorectal cancer patients: a predictive proteomic signature.", "resolution_checked_at": "2026-10-31T18:35:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:29681787:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:68526178f158fa1a73fac12b97c5bcf1740f4c6fb9c80c26dfcb0f8e840269dc", "bytes": 1462, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[3]/table-wrap[1]#Tab1", "version": null, "note": "Baseline patient characteristics", "structure": {"pmcid": "PMC5898006", "section_index": 3, "section_title": "Study design and clinical protocol", "row_count": 27, "column_count": 6}, "table": {"label": "Table 1", "caption": "Baseline patient characteristics", "rows": [["Characteristics", "All patients23 (100)a", "NR7 (30)", "PR10 (43)", "TR6 (26)", "p valueb"], ["Age (years)", "", "", "", "", ""], ["Median", "58.6 ± 11.1", "54.7 ± 14.3", "59.7 ± 10.2", "61.3 ± 8.6", ""], ["Range", "31–75", "31–72", "47–75", "48–71", ""], ["Sex", "", "", "", "", "0.324"], ["Male", "19 (83)", "7 (100)", "7 (70)", "5 (83)", ""], ["Female", "4 (17)", "0", "3 (30)", "1 (17)", ""], ["Tumor location from anal verge (cm)", "", "", "", "", "0.961"], ["3–5", "10 (43)", "3 (43)", "5 (50)", "2 (33)", ""], ["6–10", "11 (48)", "3 (43)", "4 (40)", "4 (67)", ""], ["> 10", "2 (9)", "1 (14)", "1 (10)", "0", ""], ["Tumor differentiation", "", "", "", "", "0.884"], ["Missing value", "9 (39)", "3 (43)", "3 (30)", "3 (50)", ""], ["Well", "5 (22)", "2 (29)", "2 (20)", "1 (17)", ""], ["Moderately", "9 (39)", "2 (29)", "5 (50)", "2 (33)", ""], ["Undifferentiated", "0", "0", "0", "0", ""], ["Pre-treatment stage", "", "", "", "", "0.441"], ["IIA", "3 (13)", "0", "2 (20)", "1 (17)", ""], ["IIIA", "1 (4)", "0", "1 (10)", "0", ""], ["IIIA–IIIB", "2 (9)", "0", "0", "2 (33)", ""], ["IIIB", "4 (17)", "1 (14)", "2 (20)", "1 (17)", ""], ["IIIB–IIIC", "12 (52)", "5 (71)", "5 (50)", "2 (33)", ""], ["IIIC", "1 (4)", "1 (14)", "0", "0", ""], ["iT", "", "", "", "", "0.560"], ["T2", "3 (13)", "0", "1 (10)", "2 (33)", ""], ["T3", "18 (78)", "6 (86)", "8 (80)", "4 (67)", ""], ["T4", "2 (9)", "1 (14)", "1 (10)", "0", ""]], "row_count": 27, "column_count": 6, "numeric_cells": 92, "header_rows": 1, "locator": "section[3]/table-wrap[1]#Tab1"}}, {"id": "asset:table:pmid:29681787:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:039fbae5bd86cb235ff2fbf6c907d0b5f642a8fd87906283c36ab717b9029cca", "bytes": 1520, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[1]#Tab2", "version": null, "note": "Surgical treatment and complications", "structure": {"pmcid": "PMC5898006", "section_index": 17, "section_title": "Surgical treatment and complications", "row_count": 29, "column_count": 6}, "table": {"label": "Table 2", "caption": "Surgical treatment and complications", "rows": [["Characteristics", "All patients23 (100%)a", "NR7 (30%)", "PR10 (43%)", "TR6 (26%)", "p valueb"], ["Radiotherapy", "", "", "", "", "0.822"], ["45 Gy", "1 (4)", "0", "1 (10)", "0", ""], ["45 Gy + 5.4 Gy", "21 (91)", "6 (86)", "9 (90)", "6 (100)", ""], ["50.5 Gy", "1 (4)", "1 (14)", "0", "0", ""], ["Chemotherapy", "", "", "", "", "3.2e−05"], ["Xeloda®", "22 (96)", "7 (100)", "9 (90)", "6 (100)", ""], ["5-FU", "1 (4)", "0", "1 (10)", "0", ""], ["Radiodermatitis", "", "", "", "", "0.962"], ["−", "7 (30)", "2 (29)", "3 (30)", "2 (33)", ""], ["Non-severe", "13 (57)", "4 (57)", "5 (50)", "4 (67)", ""], ["Severe", "3 (13)", "1 (14)", "2 (20)", "0", ""], ["Proctitis", "", "", "", "", "0.211"], ["+", "11 (48)", "2 (29)", "7 (70)", "2 (33)", ""], ["−", "12 (52)", "5 (71)", "3 (30)", "4 (67)", ""], ["Colitis", "", "", "", "", "1"], ["+", "0", "0", "0", "0", ""], ["−", "23 (100)", "7 (100)", "10 (100)", "6 (100)", ""], ["Mucositis", "", "", "", "", "1"], ["+", "0", "0", "0", "0", ""], ["−", "23 (100)", "7 (100)", "10 (100)", "6 (100)", ""], ["Surgical resection type", "", "", "", "", "0.004"], ["Low anterior", "17 (74)", "7 (100)", "8 (80)", "2 (33)", ""], ["Abdomino-perineal", "2 (9)", "0", "2 (20)", "0", ""], ["Endo-anal", "1 (4)", "0", "0", "1 (17)", ""], ["Refused", "3 (13)", "0", "0", "3 (50)", ""], ["Surgery delay", "", "", "", "", ""], ["Median", "8.6 ± 2.8", "9.3 ± 2.7", "8.3 ± 3.1", "8.1 ± 2.6", ""], ["Range", "1.4–13.1", "5.3–13.1", "1.4–12.9", "6.0–11.0", ""]], "row_count": 29, "column_count": 6, "numeric_cells": 95, "header_rows": 1, "locator": "section[17]/table-wrap[1]#Tab2"}}, {"id": "asset:table:pmid:29681787:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:17e17bd057aafd7a6687321e931f8b5d7cb34e8bc78e0e633bd25d8365c8f272", "bytes": 1312, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[18]/table-wrap[1]#Tab3", "version": null, "note": "Post-treatment patient characteristics", "structure": {"pmcid": "PMC5898006", "section_index": 18, "section_title": "Neoadjuvant chemoradiotherapy post-treatment results", "row_count": 26, "column_count": 6}, "table": {"label": "Table 3", "caption": "Post-treatment patient characteristics", "rows": [["Characteristics", "All patients 23 (100%)a", "NR 7 (30%)", "PR 10 (43%)", "TR 6 (26%)", "p valueb"], ["Tumor diff. after treatment", "", "", "", "", "0.064"], ["No surgery", "3 (13)", "0", "0", "3 (50)", ""], ["Missing value", "5 (22)", "2 (29)", "1 (10)", "2 (33)", ""], ["Well", "5 (22)", "1 (14)", "4 (40)", "0", ""], ["Moderately", "9 (39)", "3 (43)", "5 (50)", "1 (17)", ""], ["Undifferentiated", "1 (4)", "1 (14)", "0", "0", ""], ["Post-treatment stage", "", "", "", "", "3.3e−08"], ["0", "6 (26)", "0", "0", "6 (100)", ""], ["I", "7 (30)", "0", "7 (70)", "0", ""], ["IIA", "3 (13)", "2 (29)", "1 (10)", "0", ""], ["IIIA", "2 (9)", "0", "2 (20)", "0", ""], ["IIIB", "2 (9)", "2 (29)", "0", "0", ""], ["IIIB–IIIC", "3 (13)", "3 (43)", "0", "0", ""], ["ypT", "", "", "", "", "4.6e−08"], ["T0", "6 (26)", "0", "0", "6 (100)", ""], ["T1", "3 (13)", "0", "3 (30)", "0", ""], ["T2", "6 (26)", "0", "6 (60)", "0", ""], ["T3", "7 (30)", "6 (86)", "1 (10)", "0", ""], ["T4", "1 (4)", "1 (14)", "0", "0", ""], ["PNI", "", "", "", "", "1"], ["+", "2 (9)", "1 (14)", "1 (10)", "0", ""], ["−", "21 (91)", "6 (86)", "9 (90)", "6 (100)", ""], ["LVI", "", "", "", "", "0.002"], ["+", "8 (35)", "6 (86)", "2 (20)", "0", ""], ["−", "15 (65)", "1 (14)", "8 (80)", "6 (100)", ""]], "row_count": 26, "column_count": 6, "numeric_cells": 90, "header_rows": 1, "locator": "section[18]/table-wrap[1]#Tab3"}}, {"id": "asset:table:pmid:29681787:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:ee58fe6a84ea3505ccb78f22335b267edb0974965969b49c86b57ad486de896f", "bytes": 501, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[19]/table-wrap[1]#Tab4", "version": null, "note": "Numbers of differentially abundant proteins between each group of responders", "structure": {"pmcid": "PMC5898006", "section_index": 19, "section_title": "Identification of differentially abundant proteins between groups", "row_count": 7, "column_count": 5}, "table": {"label": "Table 4", "caption": "Numbers of differentially abundant proteins between each group of responders", "rows": [["", "Total", "NR", "PR", "TR"], ["NR versus PR versus TRa", "402", "", "", ""], ["NR versus PRb", "384", "180", "204", ""], ["NR versus TRb", "248", "139", "", "109"], ["PR versus TRb", "417", "", "294", "123"], ["NR versus PR + TRb", "282", "139", "143", ""], ["NR + PR versus TRb", "368", "93", "275", ""]], "row_count": 7, "column_count": 5, "numeric_cells": 16, "header_rows": 1, "locator": "section[19]/table-wrap[1]#Tab4"}}], "gaps": ["asset:data:geo:PXD008440 not downloaded", "asset:data:geo:PXD008440 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "anova", "label": "Group comparison", "dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "expressible": true, "parameters": {"p_value": ", both corrected with a p value of 0"}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Finally, the analysis of mass spectrometry data were next carried out with the Perseus software package [19] and subjected to a normalization (z-score) and an ANOVA statistical test (comparison of the three groups) or Student’s T test (comparison of two groups), both corrected with a p value of 0.05."}}], "targets": [{"id": "target-published-estimate", "claim_id": "claim-target-result", "operation": "bootstrap_mean_difference", "expected_value": 0.05, "unit": "p-value", "tolerance": null, "state": "complete", "note": "The threshold the paper applied to its own result, as the paper states it. A run that reproduces the effect is judged against this threshold."}], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: anova."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD008440"], "resolved_accessions": ["PXD008440"], "statements": ["All the datasets included in the present manuscript are presented in the main manuscript or additional supporting files. The complete data, including the raw files and all extracted peptides information can be found at the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD008440."], "basis": "The paper names PXD008440 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "assets": ["source:pmid:29681787", "data:geo:PXD008440", "asset:table:pmid:29681787:1", "asset:table:pmid:29681787:2", "asset:table:pmid:29681787:3", "asset:table:pmid:29681787:4"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD008440"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:34:24Z", "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 8, "usage": {"prompt_tokens": 108044, "completion_tokens": 3578, "cached_tokens": 1560}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:29681787", "type": "paper", "label": "pmid:29681787"}, {"id": "source:pmid:29681787", "type": "manuscript", "label": "PMID 29681787 full text"}, {"id": "data:geo:PXD008440", "type": "dataset", "label": "GEO PXD008440"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:29681787", "type": "paper", "label": "pmid:29681787"}, {"id": "source:pmid:29681787", "type": "manuscript", "label": "PMID 29681787 full text"}, {"id": "data:geo:PXD008440", "type": "dataset", "label": "GEO PXD008440"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-29681787", "type": "extraction", "used": ["source:pmid:29681787"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD008440", "type": "accession_resolution", "used": ["data:geo:PXD008440"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:29681787", "parent_hash": "sha256:b2ff0fd46bd727ca4c5b476eb7f10e25795e2009efa80bd21c72c17105d872ea", "fork_of": null, "generation": 7}, "gaps": ["asset:data:geo:PXD008440 licence not read", "asset:data:geo:PXD008440 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["tial responders, RT radiotherapy, TMA tissue microarray, TR total responders Table 1Baseline patient", "the paraffin blocks (Fig. 2b) using a Tissue Microarray (TMA) Master II (3DHISTECH) (Fig. 1b).Fig. 2", "formalin-fixed paraffin-embedded, TMA tissue microarray Statistical analysis The different groups of"], "order_basis": "paper_text_order:6711", "id": "assay:1"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Finally, the analysis of mass spectrometry data were next carried out with the Perseus software package [19] and subjected to a normalization (z-score) and an ANOVA statistical test (comparison of the three groups) or Student’s T test (comparison of two groups), both corrected with a p value of 0.05."], "order_basis": "consumes_earlier_output", "id": "assay:2"}]},"meta":{"api_version":"v1","automation_ladder_snapshot":"ba34b49490d9bfaf","automation_ladder_caveats":["Method extraction is rule-based and has no hand-judged accuracy sample. Evidence bands order textual support; method agreement intervals are null (n=0), never probabilities. Work-type validation does not validate methods.","Operation coverage describes only explicitly named methods. It does not prove a complete protocol, compatible parameters, successful compilation or re-execution. Unrecognised or ambiguous methods require review.","Data reachability is a textual accession or public-data statement. No dataset was downloaded or checked for access, completeness or licence.","Capabilities are planning states seeded from the dated equipment register. No bench ownership, completed quote or partner booking is inferred. Procurement counts are dependencies, not guaranteed replications or financial returns.","Tier and blocker counts are deterministic assessments of this corpus, not measured agreement. R3 is reserved for procurement; unresolved methods and data require human work (R4). The most restrictive axis wins, with capability, method, data as tie-breaks. Resolving one blocker can leave another at the same tier."],"engine":"corpus_engine","engine_provider":"rule_based_v1+lex99e1195c7d6f","run_id":"run-20261023T122449232913","source":"esearch","source_detail":"PubMed mirror biomed_pubmed (read-only)","run_status":"complete","imported_at":"2026-11-03T20:16:52+00:00","generated_at":"2026-11-04T01:43:36+00:00","total_papers":5529,"total_assays_tracked":29,"automatable_assay_families":6,"validated":true,"caveat_count":9,"blocking_caveats":5,"caveats":[{"code":"low_evidence_dominates","basis":["4,152 of 5,529 classifications (75.1%) matched no cue evidence and sit at the 0.05 floor.","34 of 230 data_only calls (14.8%) are in that group."],"claim":"Work type and confidence bands","gloss":"Most records were classified from their title and framing alone, with assay-cue coverage at zero.","detail":"Most classifications in this run rest on no matched evidence at all. At the evidence floor the work type comes from title framing and a fixed prior, not from anything in the paper, so the published work-type split should be read as a rough triage signal rather than a measured distribution. The impact is bounded but not removed: since 2026-10-23 the engine excludes floor-confidence records from the shortlist entirely and publishes them separately as held out, so the recommendation is unaffected even though the census is.","status":"unverified","severity":"high"},{"code":"runtime_is_modelled","basis":["Runtime is summed from published per-assay hour figures. Timing awaits the first executed replication.","4,407 of 5,529 records (79.7%) model to 0.00 hours because no assay was matched, which the ranking then reads as \"cheapest\".","0 of 10 shortlisted records carry a 0.00-hour estimate."],"claim":"Estimated replication runtime","gloss":"The hour figures are estimates built from assay mentions; timing awaits the first executed replication.","detail":"The hour figures are a cost model derived from the bench steps implied by each matched assay family. The first executed replication will supply measured timing. Records without an assay match currently receive a zero-hour model value.","status":"unverified","severity":"high"},{"code":"signal_score_without_citations","basis":["5,529 of 5,529 records (100.0%) have no citation count from the source metadata."],"claim":"Signal score","gloss":"The signal score uses publication-type weight because the mirror supplied zero citation counts.","detail":"The source supplied no citation counts for any record in this run, so the signal score is publication-type weight only. The citation term of the ranking is inert here, and the shortlist is ordered by publication type alone.","status":"unverified","severity":"high"},{"code":"abstract_absent","basis":["1,667 of 5,529 records (30.2%) carry no abstract at all."],"claim":"Evidence base for classification","gloss":"Some records contain a title and publication type only, defining the available classification evidence.","detail":"Where the mirror contains a title and publication types only, those fields define the classifier evidence. A methods section is required for fuller automated and human review.","status":"unverified","severity":"medium"},{"code":"classifier_agreement_measured","basis":["Published two-way decision agreement 77.7% (310 of 399 decidable records) from a stratified hand-check of 438 real records.","Three-way diagnostic agreement 73.9% (288 of 390 decidable records).","data_only agreement 75.2% (100 of 133 decidable).","48 record(s) could not be decided from title and abstract and were excluded from the denominator.","56 analysis-only records were published under another work type, so the data_only share is not an upper bound."],"claim":"Published automatable decision","gloss":"This figure has been checked against a human reading the same papers, so we know how often it is right.","detail":"The published automatable / not-automatable distribution comes from a rule-based classifier that was hand-checked against a fixed ground-truth definition. The agreement rates below are measured, not estimated. The three-way work type remains a diagnostic and is reported separately.","status":"measured","severity":"high"},{"code":"llm_comparison_not_measured","basis":["rule_based_v1+lex99e1195c7d6f produced 5,529 of 5,529 classifications.","Measured on 438 labelled records; these are RULE-BASED figures, not model results."],"claim":"Rule-based versus LLM agreement","gloss":"Every number here is the rule engine’s own. Model comparison begins when a working API credential is connected and measured.","detail":"The published two-way decision agreed with a human reading on 310 of 399 decidable records (77.7%). The diagnostic three-way label agreed on 288 of 390 decidable records (73.9%). Every percentage in this run belongs to the rule engine. Model comparison begins when a working API credential is connected and measured.","status":"not_measured","severity":"high"},{"code":"confidence_is_a_band","basis":["low band: 135 of 210 hand-judged records were correct, 64.3% [57.6, 70.5] (95% CI).","medium band: 80 of 104 hand-judged records were correct, 76.9% [68.0, 84.0] (95% CI).","high band: 73 of 76 hand-judged records were correct, 96.0% [89.0, 98.7] (95% CI).","A fitted calibrated probability was built, measured and withdrawn: it overstated held-out accuracy and reorders nothing."],"claim":"Confidence band and evidence score","gloss":"The confidence band carries a measured accuracy interval; 0.85 represents relative rank strength.","detail":"Confidence on this run is a BAND plus its measured accuracy interval. The number stored alongside each record is a monotone evidence score that orders records; 0.85 represents relative rank strength. A fitted probability was withdrawn after it overstated held-out accuracy. Threshold on the band.","status":"measured","severity":"medium"},{"code":"three_way_split_is_diagnostic","basis":["The corpus is published at the two-way decision: automatable or not-automatable. The three-way split (data_only / physical / mixed) is published as a diagnostic with its measured reliability attached, not as a claim, because the rule engine's `mixed` call cannot be defended.","The engine called 22 record(s) mixed; 10 matched the human judgement (45.5%, 95% CI 26.9-65.3).","The engine's `mixed` call is right on 10/22 hand-judged records (45.5%, 95% CI 26.9%-65.3%); a constant `physical` guess scores 36.4%.","The engine's `mixed` call does not reliably beat a constant `physical` guess on the hand-judged records it labels mixed.","The sign of that difference flips between two independent samples, so the three-way refinement is not demonstrably informative.","The mixed stratum contributes a disproportionate share of errors relative to its size.","At title-only depth the physical/mixed split collapses: a title says that work was done, not whether it was also analysed."],"claim":"The published decision is two-way","gloss":"The three-way split is shown for diagnosis only. The published split is two ways.","detail":"Count and filter the corpus on automatable versus not-automatable. The data_only / physical / mixed split remains an internal engine diagnostic because the mixed call has lower measured reliability.","status":"measured","severity":"medium"},{"code":"automatable_flag_unproven","basis":["6 of 29 assay families are marked automatable now: meta_analysis, machine_learning, survival_analysis, pca, molecular_docking, differential_expression.","The flag is a rule over assay family and work type; validation begins with the first executed replication.","It inherits the 75.2% data_only agreement rate, because the flag requires the record to be analysis-only."],"claim":"Automatable now","gloss":"This flag marks assay families the rules classify as data-only. The first executed replication will validate it.","detail":"This flag marks families the rules consider replicable from data alone. Its validity depends on the analysis-only classification and will be measured through an executed replication.","status":"unverified","severity":"medium"}],"confidence_policy":"band_with_measured_interval","confidence_contract":{"policy":"band_with_measured_interval","summary":"Confidence is reported as a BAND with a measured accuracy interval. The raw evidence score supplies monotone ordering. A fitted point estimate was withdrawn after it overstated held-out accuracy.","evidence_score":"A monotone evidence score in [0,1] built from cue mass, axis separation and text coverage. Use it to order records. Interpret 0.85 as relative rank strength.","confidence_band":"low | medium | high. Consumers threshold on this value.","band_accuracy":"Wilson 95% interval on the measured agreement of the hand-judged records in this band.","calibrated_confidence":"WITHDRAWN. Reintroduction requires held-out evidence demonstrating reliable estimates across every bin."},"band_accuracy":{"low":{"n":210,"low":0.576,"band":"low","high":0.7046,"agree":135,"accuracy":0.6429},"high":{"n":76,"low":0.8903,"band":"high","high":0.9865,"agree":73,"accuracy":0.9605},"medium":{"n":104,"low":0.6795,"band":"medium","high":0.8397,"agree":80,"accuracy":0.7692}},"provider":"rule_based_v1+lex99e1195c7d6f","lexicon_id":"99e1195c7d6f","contract_published_at":"2026-10-23T12:25:29.022232+00:00","confidence_is_band":true,"confidence_is_probability":false,"decision_taxonomy":"two_way","decidable_fraction_two_way":0.8854,"decidable_fraction_two_way_low":0.8565,"decidable_fraction_two_way_high":0.9143,"decidable_fraction_three_way":0.8586,"decidable_fraction_three_way_low":0.8287,"decidable_fraction_three_way_high":0.8884,"decidable_population":5529,"validation_sample_size":438,"three_way_cost_fraction":0.0268,"three_way_cost_records":148,"decision_counts":{"automatable":230,"not_automatable":5299},"decision_split":{"automatable":{"count":230,"share":0.04159884246699222},"not_automatable":{"count":5299,"share":0.9584011575330078}},"diagnostic_work_type_counts":{"mixed":24,"physical":5275,"data_only":230}}}